NCT00674843

The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies

Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation to Manage or Treat Muscular Dystrophies.

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 4 (actual)
• Sponsor: GAAD Medical Research Institute Inc. · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The muscular dystrophies (MD) are a group of more than 30 neuromuscular disorders that are characterized by progressive skeletal muscle weakness, defects in muscle proteins and the death of muscle cells and tissue. This study will investigate the use of far infrared radiation for managing muscular dystrophies.

Detailed description

Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells. It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly cure these neuromuscular disorders.

Conditions

• Muscular Dystrophies

Interventions

Type	Name	Description
RADIATION	Far Infrared Radiation	Radiation: Far Infrared Radiation (5μm to 20μm wavelength) Far Infrared radiation for 30 to 40 minutes per treatment session.

Timeline

• Start date: 2008-05-01
• Primary completion: 2010-05-01
• Completion: 2010-06-01
• First posted: 2008-05-08
• Last updated: 2009-08-17

Locations

1 site across 1 country: Canada